CVAC Prakiraan volume dodolan CureVac Corp

Simbol resmi perusahaan CureVac N.V. (CVAC)

Leveraging unique RNA platform patents and strict regulatory oversight, CureVac N.V. (CVAC) has established a protective moat based on an innovative vaccine architecture with optimized coding. The company's sales expectations reflect current trends, where 0.08 shows the actual metric value. CureVac N.V. (CVAC) is now transitioning to an autonomous development cycle, focusing on oncology therapies and emerging infections.

CureVac N.V. - Prakiraan volume dodolan CVAC (periode 04.07.2022 - 17.01.2026)

Ringkesan rincian data analitis CureVac N.V. (CVAC)

- nilai saham lan prakiraan konsensus rega:
Bagan rega CureVac NV|CVAC - Target median analis
- data kapitalisasi pasar:
Kapitalisasi pasar CureVac|CVAC - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- informasi kapitalisasi buku:
Nilai Akuntansi saben Saham CureVac|CVAC - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku curevac.com|CVAC - Nilai Agregat Aset
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal CureVac N.V.|CVAC - Kewajiban jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas CureVac N.V.|CVAC - Utang perusahaan|Utang-utang marang kapitalisasi buku CureVac Corp|CVAC - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan CureVac|Indikator likuiditas cepet curevac.com
- rincian asil keuangan lan kelipatan valuasi:
CVAC - Bathi pungkasan|Bathi sing dikarepake CureVac N.V.|CVAC - Pangali rega marang bathi|Prakiraan rega marang bathi CureVac Pharma|CVAC - Kapitalisasi marang bathi resik kanthi nimbang wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan CureVac Pharma|CVAC - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan CureVac|CVAC - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan curevac.com|CVAC - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep CureVac N.V.
- indikator volume dodolan lan pendapatan:
CVAC - Pendapatan perusahaan|Prakiraan volume dodolan curevac.com|CVAC - Multiplikator P/S|Multiplikator Forward P/S CureVac
Analisis umum perusahaan:curevac.com
Produk merek CureVac Pharma

This indicator aggregates market consensus estimates for future cash flows, filtering out short-term noise and capturing traders' actual revenue expectations. By analyzing the company's projected sales volumes, investors can track the trend of expected royalties and upfront payments from GSK, which is critical for assessing the commercialization of CureVac N.V. (CVAC) mRNA technologies within the vaccine and oncology segments.

Analisis perusahaan pesaing

Prakiraan pendapatan perusahaan Gilead (GILD)|Dodolan mangsa ngarep perusahaan Cidara Therapeutics Inc|Prakiraan pendapatan perusahaan Novavax, Inc. NVAX|Valneva Pharma - Prakiraan pendapatan perusahaan|VIR - Prakiraan pendapatan perusahaan|Dodolan mangsa ngarep perusahaan SIGA Technologies, Inc. SIGA|Emergent BioSolutions Inc. (EBS) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Atea Pharmaceuticals, Inc. (AVIR)|IVVD (Invivyd) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan ENTA (Enanta Pharmaceuticals)|Prakiraan pendapatan perusahaan Inovio Pharmaceuticals, Inc. (INO)|HLVX - Volume dodolan sing dikarepake perusahaan|Prakiraan volume dodolan KLRS (Kalaris Therapeutics Inc.)|DYAI - Volume dodolan mangsa ngarep perusahaan|NNVC - Prakiraan pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan TLPH (Talphera Corp)|COCP: Prakiraan volume dodolan|Traws Pharma Inc - Pendapatan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan DWTX|QLGN: Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan AlloVir Bio (ALVR)|VBI Vaccines - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan Virios Therapeutics VIRI|Dodolan mangsa ngarep perusahaan vaxart.com (VXRT)